These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35980466)

  • 1. Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort.
    Montano V; Lopriore P; Gruosso F; Carelli V; Comi GP; Filosto M; Lamperti C; Mongini T; Musumeci O; Servidei S; Tonin P; Toscano A; Primiano G; Valentino ML; Bortolani S; Marchet S; Ricci G; Modenese A; Cotti Piccinelli S; Risi B; Meneri M; Arena IG; Siciliano G; Mancuso M
    J Neurol; 2022 Dec; 269(12):6555-6565. PubMed ID: 35980466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy.
    Montano V; Gruosso F; Carelli V; Comi GP; Filosto M; Lamperti C; Mongini T; Musumeci O; Servidei S; Tonin P; Toscano A; Modenese A; Primiano G; Valentino ML; Bortolani S; Marchet S; Meneri M; Tavilla G; Siciliano G; Mancuso M
    Neurol Genet; 2020 Dec; 6(6):e519. PubMed ID: 33209982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting mitochondrial ocular myopathies: a study from the Italian Network.
    Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Federico A; Minetti C; Moggio M; Mongini T; Santorelli FM; Servidei S; Tonin P; Ardissone A; Bello L; Bruno C; Ienco EC; Diodato D; Filosto M; Lamperti C; Moroni I; Musumeci O; Pegoraro E; Primiano G; Ronchi D; Rubegni A; Salvatore S; Sciacco M; Valentino ML; Vercelli L; Toscano A; Zeviani M; Siciliano G; Mancuso M
    J Neurol; 2017 Aug; 264(8):1777-1784. PubMed ID: 28695364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. People at a persistent pain service can walk it, but some struggle to talk about it: Reliability, detectable difference and clinically important difference of the six-minute walk test.
    Murdoch M; Window P; Morton C; O'Donohue R; Ballard E; Claus A
    Musculoskeletal Care; 2023 Mar; 21(1):221-231. PubMed ID: 36065494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.
    Witherspoon JW; Vasavada RP; Waite MR; Shelton M; Chrismer IC; Wakim PG; Jain MS; Bönnemann CG; Meilleur KG
    Orphanet J Rare Dis; 2018 Jul; 13(1):105. PubMed ID: 29970108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.
    Spina E; Topa A; Iodice R; Tozza S; Ruggiero L; Dubbioso R; Esposito M; Dolce P; Santoro L; Manganelli F
    J Neurol; 2019 Apr; 266(4):860-865. PubMed ID: 30721354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies.
    Gervasoni J; Primiano A; Marini F; Sabino A; Biancolillo A; Calvani R; Picca A; Marzetti E; Persichilli S; Urbani A; Servidei S; Primiano G
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33352713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive external ophthalmoplegia associated with novel MT-TN mutations.
    Visuttijai K; Hedberg-Oldfors C; Lindgren U; Nordström S; Elíasdóttir Ó; Lindberg C; Oldfors A
    Acta Neurol Scand; 2021 Jan; 143(1):103-108. PubMed ID: 32869280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal clinically important difference for improvement in six-minute walk test in persons with knee osteoarthritis after total knee arthroplasty.
    King LK; Hawker GA; Stanaitis I; Woodhouse L; Jones CA; Waugh EJ
    BMC Musculoskelet Disord; 2022 Mar; 23(1):307. PubMed ID: 35361173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous mutations in C1QBP as cause of progressive external ophthalmoplegia (PEO) and mitochondrial myopathy with multiple mtDNA deletions.
    Marchet S; Legati A; Nasca A; Di Meo I; Spagnolo M; Zanetti N; Lamantea E; Catania A; Lamperti C; Ghezzi D
    Hum Mutat; 2020 Oct; 41(10):1745-1750. PubMed ID: 32652806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy.
    Karaa A; Haas R; Goldstein A; Vockley J; Cohen BH
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):909-918. PubMed ID: 32096613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia.
    Dengler R; Wohlfarth K; Zierz S; Jobges M; Schubert M
    Muscle Nerve; 1996 Apr; 19(4):456-62. PubMed ID: 8622724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.
    Karaa A; Haas R; Goldstein A; Vockley J; Weaver WD; Cohen BH
    Neurology; 2018 Apr; 90(14):e1212-e1221. PubMed ID: 29500292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal clinically important difference of the 6-min walking test in patients with asthma.
    Zampogna E; Ambrosino N; Centis R; Cherubino F; Migliori GB; Pignatti P; Lo Bello G; Saderi L; Sotgiu G; Zappa M; Spanevello A; Visca D
    Int J Tuberc Lung Dis; 2021 Mar; 25(3):215-221. PubMed ID: 33688810
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a Patient-Reported Outcome Questionnaire to Evaluate Primary Mitochondrial Myopathy Symptoms: The Primary Mitochondrial Myopathy Symptom Assessment.
    Gwaltney C; Stokes J; Aiudi A; Mazar I; Ollis S; Love E; Espensen A; Shields AL
    J Clin Neuromuscul Dis; 2020 Dec; 22(2):65-76. PubMed ID: 33214391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic asymmetric progressive external ophthalmoplegia with right facial weakness: a unique presentation of mitochondrial myopathy.
    Sharma NK; Gujrati M; Kumar J; Kattah JC
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):95. PubMed ID: 12082069
    [No Abstract]   [Full Text] [Related]  

  • 18. The 6-min walk test in the functional evaluation of patients with lung cancer qualified for lobectomy.
    Wesolowski S; Orlowski TM; Kram M
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):559-564. PubMed ID: 32068846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication.
    Sandberg A; Cider Å; Jivegård L; Nordanstig J; Wittboldt S; Bäck M
    J Vasc Surg; 2020 Jan; 71(1):197-203. PubMed ID: 31147129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.
    Nathan SD; du Bois RM; Albera C; Bradford WZ; Costabel U; Kartashov A; Noble PW; Sahn SA; Valeyre D; Weycker D; King TE
    Respir Med; 2015 Jul; 109(7):914-22. PubMed ID: 25956020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.